Update of the tolerable upper intake level for vitamin D for infants

K. Pentieva, Dominique Turck, Jean‐Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather‐Tait, Marina Heinonen, Karen Ildico Hirsch‐Ernst, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Grazyna Nowicka, Yolanda Sanz, Alfonso Siani, Anders Sjodin, Martin Stern, Daniel Tome, Henk Van Loveren, Marco Vinceti, Peter Willatts & 9 others Mary Fewtrell, Christel Lamberg-Allardt, Hildegard Przyrembel, Davide Arcella, Celine Dumas, Lucia Fabiani, Laura Martino, Daniela Tomcikova, Monika Neuhauser-Berthold

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to revise the tolerable upper intake level (UL) for vitamin D for infants (≤ 1 year) set in 2012. From its literature review, the Panel concluded that the available evidence on daily vitamin D intake and the risk of adverse health outcomes (hypercalciuria, hypercalcaemia, nephrocalcinosis and abnormal growth patterns) cannot be used alone for deriving the UL for infants. The Panel conducted a meta‐regression analysis of collected data, to derive a dose–response relationship between daily supplemental intake of vitamin D and mean achieved serum 25(OH)D concentrations. Considering that a serum 25(OH)D concentration of 200 nmol/L or below is unlikely to pose a risk of adverse health outcomes in infants, the Panel estimated the percentage of infants reaching a concentration above this value at different intakes of vitamin D. Based on the overall evidence, the Panel kept the UL of 25 μg/day for infants aged up to 6 months and set a UL of 35 μg/day for infants 6–12 months. The Panel was also asked to advise on the safety of the consumption of infant formulae with an increased maximum vitamin D content of 3 μg/100 kcal (Commission Delegated Regulation (EU) 2016/127 repealing Directive 2006/141/EC in 2020). For infants aged up to 4 months, the intake assessment showed that the use of infant formulae containing vitamin D at 3 μg/100 kcal may lead some infants to receive an intake above the UL of 25 μg/day from formulae alone without considering vitamin D supplemental intake. For infants aged 4–12 months, the 95th percentile of vitamin D intake (high consumers) estimated from formulae and foods fortified or not with vitamin D does not exceed the ULs, without considering vitamin D supplemental intake.
LanguageEnglish
Number of pages118
JournalEFSA Journal
Volume16
Issue number8
DOIs
Publication statusPublished - 7 Aug 2018

Fingerprint

Vitamin D
Infant Formula
Cholecalciferol
Fortified Food
Nephrocalcinosis
Hypercalciuria
Dietetics
Health
Hypercalcemia
Serum
Meta-Analysis
Hypersensitivity
Regression Analysis
Safety
Growth

Keywords

  • vitamin D
  • infants
  • adverse health outcome
  • 25(OH)D
  • UL
  • Intake

Cite this

Pentieva, K., Turck, D., Bresson, JL., Burlingame, B., Dean, T., Fairweather‐Tait, S., ... Neuhauser-Berthold, M. (2018). Update of the tolerable upper intake level for vitamin D for infants. EFSA Journal, 16(8). https://doi.org/10.2903/j.efsa.2018.5365
Pentieva, K. ; Turck, Dominique ; Bresson, Jean‐Louis ; Burlingame, Barbara ; Dean, Tara ; Fairweather‐Tait, Susan ; Heinonen, Marina ; Ildico Hirsch‐Ernst, Karen ; Mangelsdorf, Inge ; McArdle, Harry J ; Naska, Androniki ; Nowicka, Grazyna ; Sanz, Yolanda ; Siani, Alfonso ; Sjodin, Anders ; Stern, Martin ; Tome, Daniel ; Van Loveren, Henk ; Vinceti, Marco ; Willatts, Peter ; Fewtrell, Mary ; Lamberg-Allardt, Christel ; Przyrembel, Hildegard ; Arcella, Davide ; Dumas, Celine ; Fabiani, Lucia ; Martino, Laura ; Tomcikova, Daniela ; Neuhauser-Berthold, Monika. / Update of the tolerable upper intake level for vitamin D for infants. In: EFSA Journal. 2018 ; Vol. 16, No. 8.
@article{ae04e9c20b09460f971a2c205fd9276b,
title = "Update of the tolerable upper intake level for vitamin D for infants",
abstract = "Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to revise the tolerable upper intake level (UL) for vitamin D for infants (≤ 1 year) set in 2012. From its literature review, the Panel concluded that the available evidence on daily vitamin D intake and the risk of adverse health outcomes (hypercalciuria, hypercalcaemia, nephrocalcinosis and abnormal growth patterns) cannot be used alone for deriving the UL for infants. The Panel conducted a meta‐regression analysis of collected data, to derive a dose–response relationship between daily supplemental intake of vitamin D and mean achieved serum 25(OH)D concentrations. Considering that a serum 25(OH)D concentration of 200 nmol/L or below is unlikely to pose a risk of adverse health outcomes in infants, the Panel estimated the percentage of infants reaching a concentration above this value at different intakes of vitamin D. Based on the overall evidence, the Panel kept the UL of 25 μg/day for infants aged up to 6 months and set a UL of 35 μg/day for infants 6–12 months. The Panel was also asked to advise on the safety of the consumption of infant formulae with an increased maximum vitamin D content of 3 μg/100 kcal (Commission Delegated Regulation (EU) 2016/127 repealing Directive 2006/141/EC in 2020). For infants aged up to 4 months, the intake assessment showed that the use of infant formulae containing vitamin D at 3 μg/100 kcal may lead some infants to receive an intake above the UL of 25 μg/day from formulae alone without considering vitamin D supplemental intake. For infants aged 4–12 months, the 95th percentile of vitamin D intake (high consumers) estimated from formulae and foods fortified or not with vitamin D does not exceed the ULs, without considering vitamin D supplemental intake.",
keywords = "vitamin D, infants, adverse health outcome, 25(OH)D, UL, Intake",
author = "K. Pentieva and Dominique Turck and Jean‐Louis Bresson and Barbara Burlingame and Tara Dean and Susan Fairweather‐Tait and Marina Heinonen and {Ildico Hirsch‐Ernst}, Karen and Inge Mangelsdorf and McArdle, {Harry J} and Androniki Naska and Grazyna Nowicka and Yolanda Sanz and Alfonso Siani and Anders Sjodin and Martin Stern and Daniel Tome and {Van Loveren}, Henk and Marco Vinceti and Peter Willatts and Mary Fewtrell and Christel Lamberg-Allardt and Hildegard Przyrembel and Davide Arcella and Celine Dumas and Lucia Fabiani and Laura Martino and Daniela Tomcikova and Monika Neuhauser-Berthold",
year = "2018",
month = "8",
day = "7",
doi = "10.2903/j.efsa.2018.5365",
language = "English",
volume = "16",
journal = "EFSA Journal",
issn = "1831-4732",
number = "8",

}

Pentieva, K, Turck, D, Bresson, JL, Burlingame, B, Dean, T, Fairweather‐Tait, S, Heinonen, M, Ildico Hirsch‐Ernst, K, Mangelsdorf, I, McArdle, HJ, Naska, A, Nowicka, G, Sanz, Y, Siani, A, Sjodin, A, Stern, M, Tome, D, Van Loveren, H, Vinceti, M, Willatts, P, Fewtrell, M, Lamberg-Allardt, C, Przyrembel, H, Arcella, D, Dumas, C, Fabiani, L, Martino, L, Tomcikova, D & Neuhauser-Berthold, M 2018, 'Update of the tolerable upper intake level for vitamin D for infants', EFSA Journal, vol. 16, no. 8. https://doi.org/10.2903/j.efsa.2018.5365

Update of the tolerable upper intake level for vitamin D for infants. / Pentieva, K.; Turck, Dominique; Bresson, Jean‐Louis ; Burlingame, Barbara; Dean, Tara; Fairweather‐Tait, Susan ; Heinonen, Marina ; Ildico Hirsch‐Ernst, Karen ; Mangelsdorf, Inge ; McArdle, Harry J ; Naska, Androniki ; Nowicka, Grazyna ; Sanz, Yolanda ; Siani, Alfonso; Sjodin, Anders ; Stern, Martin; Tome, Daniel; Van Loveren, Henk; Vinceti, Marco; Willatts, Peter; Fewtrell, Mary; Lamberg-Allardt, Christel; Przyrembel, Hildegard; Arcella, Davide; Dumas, Celine; Fabiani, Lucia; Martino, Laura; Tomcikova, Daniela; Neuhauser-Berthold, Monika.

In: EFSA Journal, Vol. 16, No. 8, 07.08.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Update of the tolerable upper intake level for vitamin D for infants

AU - Pentieva, K.

AU - Turck, Dominique

AU - Bresson, Jean‐Louis

AU - Burlingame, Barbara

AU - Dean, Tara

AU - Fairweather‐Tait, Susan

AU - Heinonen, Marina

AU - Ildico Hirsch‐Ernst, Karen

AU - Mangelsdorf, Inge

AU - McArdle, Harry J

AU - Naska, Androniki

AU - Nowicka, Grazyna

AU - Sanz, Yolanda

AU - Siani, Alfonso

AU - Sjodin, Anders

AU - Stern, Martin

AU - Tome, Daniel

AU - Van Loveren, Henk

AU - Vinceti, Marco

AU - Willatts, Peter

AU - Fewtrell, Mary

AU - Lamberg-Allardt, Christel

AU - Przyrembel, Hildegard

AU - Arcella, Davide

AU - Dumas, Celine

AU - Fabiani, Lucia

AU - Martino, Laura

AU - Tomcikova, Daniela

AU - Neuhauser-Berthold, Monika

PY - 2018/8/7

Y1 - 2018/8/7

N2 - Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to revise the tolerable upper intake level (UL) for vitamin D for infants (≤ 1 year) set in 2012. From its literature review, the Panel concluded that the available evidence on daily vitamin D intake and the risk of adverse health outcomes (hypercalciuria, hypercalcaemia, nephrocalcinosis and abnormal growth patterns) cannot be used alone for deriving the UL for infants. The Panel conducted a meta‐regression analysis of collected data, to derive a dose–response relationship between daily supplemental intake of vitamin D and mean achieved serum 25(OH)D concentrations. Considering that a serum 25(OH)D concentration of 200 nmol/L or below is unlikely to pose a risk of adverse health outcomes in infants, the Panel estimated the percentage of infants reaching a concentration above this value at different intakes of vitamin D. Based on the overall evidence, the Panel kept the UL of 25 μg/day for infants aged up to 6 months and set a UL of 35 μg/day for infants 6–12 months. The Panel was also asked to advise on the safety of the consumption of infant formulae with an increased maximum vitamin D content of 3 μg/100 kcal (Commission Delegated Regulation (EU) 2016/127 repealing Directive 2006/141/EC in 2020). For infants aged up to 4 months, the intake assessment showed that the use of infant formulae containing vitamin D at 3 μg/100 kcal may lead some infants to receive an intake above the UL of 25 μg/day from formulae alone without considering vitamin D supplemental intake. For infants aged 4–12 months, the 95th percentile of vitamin D intake (high consumers) estimated from formulae and foods fortified or not with vitamin D does not exceed the ULs, without considering vitamin D supplemental intake.

AB - Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to revise the tolerable upper intake level (UL) for vitamin D for infants (≤ 1 year) set in 2012. From its literature review, the Panel concluded that the available evidence on daily vitamin D intake and the risk of adverse health outcomes (hypercalciuria, hypercalcaemia, nephrocalcinosis and abnormal growth patterns) cannot be used alone for deriving the UL for infants. The Panel conducted a meta‐regression analysis of collected data, to derive a dose–response relationship between daily supplemental intake of vitamin D and mean achieved serum 25(OH)D concentrations. Considering that a serum 25(OH)D concentration of 200 nmol/L or below is unlikely to pose a risk of adverse health outcomes in infants, the Panel estimated the percentage of infants reaching a concentration above this value at different intakes of vitamin D. Based on the overall evidence, the Panel kept the UL of 25 μg/day for infants aged up to 6 months and set a UL of 35 μg/day for infants 6–12 months. The Panel was also asked to advise on the safety of the consumption of infant formulae with an increased maximum vitamin D content of 3 μg/100 kcal (Commission Delegated Regulation (EU) 2016/127 repealing Directive 2006/141/EC in 2020). For infants aged up to 4 months, the intake assessment showed that the use of infant formulae containing vitamin D at 3 μg/100 kcal may lead some infants to receive an intake above the UL of 25 μg/day from formulae alone without considering vitamin D supplemental intake. For infants aged 4–12 months, the 95th percentile of vitamin D intake (high consumers) estimated from formulae and foods fortified or not with vitamin D does not exceed the ULs, without considering vitamin D supplemental intake.

KW - vitamin D

KW - infants

KW - adverse health outcome

KW - 25(OH)D

KW - UL

KW - Intake

U2 - 10.2903/j.efsa.2018.5365

DO - 10.2903/j.efsa.2018.5365

M3 - Article

VL - 16

JO - EFSA Journal

T2 - EFSA Journal

JF - EFSA Journal

SN - 1831-4732

IS - 8

ER -

Pentieva K, Turck D, Bresson JL, Burlingame B, Dean T, Fairweather‐Tait S et al. Update of the tolerable upper intake level for vitamin D for infants. EFSA Journal. 2018 Aug 7;16(8). https://doi.org/10.2903/j.efsa.2018.5365